ROIVANT SCIENCES LTD. (ROIV)

SEC filing

ROIVANT SCIENCES LTD.

ROIV · CIK 1635088

4 · Aug 18, 2026 · Director, President & CIO Sukhatme Mayukh sold 664.83K Common Shares at $36.34/unit ($24.2M); exercised options for 1.33M Common Shares

Director, President & CIO Sukhatme Mayukh sold 664.83K Common Shares at $36.34/unit ($24.2M); exercised options for 1.33M Common Shares

Filed: Aug 18, 2026
Period: Aug 14, 2026
Accession: 0001140361-26-033637
Filer: Roivant Sciences Ltd.
Exhibits: EX-24

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4.xml

xslF345X06/form4.xmlSEC.gov

Exhibits

EX-24

EXHIBIT 24

ef20080615_ex24.htmSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4.xml
Open SEC.gov